Emesis iGuide Application icon

Emesis iGuide 2.0.0

7.1 MB / 10+ Downloads / Rating 4.8 - 10 reviews


See previous versions

Emesis iGuide, developed and published by Helsinn Healthcare S.A., has released its latest version, 2.0.0, on 2017-08-02. This app falls under the Medical category on the Google Play Store and has achieved over 1000 installs. It currently holds an overall rating of 4.8, based on 10 reviews.

Emesis iGuide APK available on this page is compatible with all Android devices that meet the required specifications (Android 2.3+). It can also be installed on PC and Mac using an Android emulator such as Bluestacks, LDPlayer, and others.

Read More

App Screenshot

App Screenshot

App Details

Package name: com.emesys.iguide

Updated: 8 years ago

Developer Name: Helsinn Healthcare S.A.

Category: Medical

App Permissions: Show more

Installation Instructions

This article outlines two straightforward methods for installing Emesis iGuide on PC Windows and Mac.

Using BlueStacks

  1. Download the APK/XAPK file from this page.
  2. Install BlueStacks by visiting http://bluestacks.com.
  3. Open the APK/XAPK file by double-clicking it. This action will launch BlueStacks and begin the application's installation. If the APK file does not automatically open with BlueStacks, right-click on it and select 'Open with...', then navigate to BlueStacks. Alternatively, you can drag-and-drop the APK file onto the BlueStacks home screen.
  4. Wait a few seconds for the installation to complete. Once done, the installed app will appear on the BlueStacks home screen. Click its icon to start using the application.

Using LDPlayer

  1. Download and install LDPlayer from https://www.ldplayer.net.
  2. Drag the APK/XAPK file directly into LDPlayer.

If you have any questions, please don't hesitate to contact us.

App Rating

4.8
Total 10 reviews

Previous Versions

Emesis iGuide 2.0.0
2017-08-02 / 7.1 MB / Android 2.3+

About this app

This guide is designed as a practical tool for the Oncologists, aimed at facilitating the decision making on the antiemetic therapy to be administered to patients undergoing a specific chemotherapy (CT) regimen. While it offers information on CT regimens’ schedules and emetogenicity, this guide is not a tool for CT choice. Please consult guidelines and package inserts for exact dosages, notes and warnings on CT agents and combinations.
Information included herein is based on data from the latest ASCO, ESMO, MASCC, NCCN, and NCI guidelines, and it has been integrated with relevant evidences from the international scientific literature.
This guide is a summary of cancer therapeutic agents and regimens and of their emetogenicity according to the available evidences and guidelines. Although detailed, this guide is not intended or designed as an exhaustive review. No liability will be assumed by Helsinn Healthcare SA for the use of this tool and the absence of errors, omissions, or inaccuracies is not guaranteed. For detailed information on single agents, regimens, dosages, and indications, the user is invited to consult drugs’ prescribing information as well as international literature and guidelines.
This application is intended for non-US physicians only.

App Permissions

Allows applications to open network sockets.